Mass Tort Clinical Record Analysis
AI-assisted medical record review and claimant evidence analysis designed for large-scale litigation and complex claimant populations.
Structured Medical Record Review for Large-Scale Litigation
Lexcura Summit provides clinician-led mass tort medical record review and clinical evidence analysis for complex litigation involving pharmaceuticals, medical devices, toxic exposures, and product liability claims. By integrating structured clinical review with AI-assisted evidence extraction, the methodology enables litigation teams to evaluate large claimant populations, verify injury diagnoses, and identify patterns relevant to causation, exposure, and case valuation.
Mass Tort Litigation We Support
Clinical record analysis across complex product and exposure litigation — each category reviewed under the same structured methodology.
Pharmaceutical Litigation
- Prescription medication injuries
- Adverse drug reactions
- Long-term medication complications
- Drug interaction injuries
Medical Device Litigation
- Implantable device failures
- Device migration or fracture
- Revision surgeries and complications
- Implant-related infections
Toxic Exposure & Environmental
- Industrial chemical exposure
- Contaminated water or hazards
- Occupational toxic exposure
- Long-latency disease development
Product Liability With Medical Injury
- Defective consumer products
- Cosmetic or chemical injuries
- Contaminated products
- Medical complications from product use
Mass Tort Clinical Intelligence Workflow
A disciplined, repeatable workflow that moves claimant files through screening, classification, escalation, and litigation decision-making at scale.
Record Ingestion
Collect, normalize, organize, and quality-check claimant medical records for review readiness.
Exposure Mapping
Confirm product use, timing, duration, provider involvement, and relevant exposure history.
Injury Verification
Identify documented diagnoses, diagnostic findings, treatment patterns, and injury consistency.
Causation Analysis
Evaluate temporal relationship, confounders, alternative etiologies, and medical plausibility.
Claimant Classification
Sort files by evidentiary strength, review priority, litigation fit, and escalation needs.
Bellwether / Expert Escalation
Advance stronger files for expert review, bellwether consideration, and deeper case strategy.
Tiered Claimant Review
Mass tort engagements are structured on a per-claimant basis. Files may progress through successive levels of clinical review depending on case strength, evidentiary requirements, and litigation strategy.
Claimant Eligibility Screening
High-volume screening to confirm core litigation criteria before deeper clinical review.
- Exposure documentation verification
- Diagnosis confirmation
- Preliminary clinical timeline markers
- Medical record sufficiency review
Core Clinical Record Analysis
Attorney-facing medical record analysis providing structured clinical evaluation of the claimant's medical history.
- Exposure timeline reconstruction
- Diagnosis verification
- Structured clinical chronology
- Confounder identification
- Preliminary causation assessment
Comprehensive Clinical Case Analysis
Detailed clinical evaluation for complex claims, bellwether candidates, or expert preparation.
- Full medical chronology reconstruction
- Detailed exposure analysis
- Alternative etiology evaluation
- Structured causation assessment
- Expert issue identification
- Record citation appendix
Anticipating & Countering Defense Strategy
Structured responses to the most common defense arguments in mass tort claimant litigation.
"The Product Did Not Cause the Injury"
Defense challenges causation by introducing alternative explanations and attacking clinical coherence.
Exposure & Causation Mapping
Exposure mapping, temporal alignment, diagnosis verification, and confounder separation clarify whether the medical record supports the alleged injury theory.
"Claimants Are Too Inconsistent"
Defense emphasizes variability in diagnosis, symptoms, treatment history, and medical profile across the population.
Population Pattern Analysis
Population-level pattern analysis distinguishes meaningful clinical variation from noise and identifies recurring characteristics supporting broader litigation themes.
"Preexisting Conditions Explain the Injury"
Defense attributes harm to baseline medical history rather than the claimed exposure.
Baseline Separation
Baseline health status is separated from post-exposure clinical change, allowing counsel to evaluate whether the documented injury pattern is more consistent with the litigation theory than with prior conditions.
"There Is No Temporal Link"
Weak or unclear timing is used to undermine causation even where injury is documented.
Chronology Reconstruction
Chronology reconstruction using medication history, device data, symptom development, treatment escalation, and diagnostic milestones clarifies whether the timeline supports litigation.
How Structured Intelligence Affects Portfolio Performance
Portfolio value is often lost long before trial. Structured clinical intelligence changes outcomes by changing what counsel sees early, where resources are invested, and which cases move forward.
Early Weak Case Elimination
Prevents resources from being spent on files with weak exposure proof, poor diagnostic support, or dominant alternative causes.
High-Value Claimant Identification
Surfaces stronger files earlier based on documentation strength, injury severity, chronology, and causation coherence.
Bellwether Strengthening
Improves representative case selection by using clinically stronger files rather than anecdotal impression.
Expert Efficiency
Delivers better-organized narratives and cleaner issue framing so experts spend less time reconstructing the record.
Settlement Leverage
Strengthens claimant clusters by clarifying which files have the clearest exposure, injury support, and defensible causation.
Portfolio Optimization
Supports more rational allocation of discovery, expert, and trial preparation resources across the claimant pool.
Built for Teams Managing Large Claimant Populations
Lexcura mass tort engagement is designed for litigation teams that need structured medical intelligence before major portfolio-level investment.
Plaintiff Firms Handling MDLs or Mass Tort Portfolios
Use Lexcura to screen large claimant populations, verify injury support, and build cleaner litigation inventories.
Teams Building Claimant Populations
Use structured review to identify which files should be advanced, held, or removed before deeper spend.
Firms Preparing for Bellwether Selection
Identify representative files with stronger chronology, injury support, and causation integrity.
Teams Requiring Clinical Triage Before Expert Review
Reduce expert inefficiency by sending forward organized, higher-value files rather than undifferentiated records.
Lexcura vs. Traditional Record Review
Traditional record review describes what is in the file. Lexcura structures what the file means for litigation.
| Traditional Review | Lexcura Clinical Intelligence |
|---|---|
| Chronologies and summaries | Structured clinical intelligence for litigation strategy |
| File-by-file review | Population-level pattern analysis |
| Reactive record interpretation | Strategy-driven claimant screening and escalation |
| Variable reviewer approach | Standardized analytical framework |
| Limited scalability | Designed for mass tort volume and repeatable review discipline |
Submit Your Claimant Dataset for Clinical Screening
Lexcura Summit provides structured clinical intelligence for litigation teams managing large claimant populations. We identify viable claims, eliminate weak files, and surface high-value cases before expert engagement.
Engagements are designed for firms handling 50+ claimant files, preparing for bellwether selection, or requiring disciplined clinical analysis at scale.
Typical use: 500–5,000+ claimant files across active mass tort dockets.